More about

Hiv

News
June 21, 2024
2 min read
Save

Twice-yearly shot prevents HIV in phase 3 trial, Gilead reports

Twice-yearly shot prevents HIV in phase 3 trial, Gilead reports

Lenacapavir, an injectable antiretroviral drug approved by the FDA for HIV treatment, prevented 100% of new HIV infections among women in a phase 3 trial in Africa, demonstrating its efficacy as PrEP, Gilead Sciences said.

CME
Video

HIV PrEP: Advanced Practice Providers' Toolkit for Effective Implementation

HIV PrEP: Advanced Practice Providers' Toolkit for Effective Implementation
0.75 CNE
0.75 AANP
45 MINS
$0 FEE
News
May 29, 2024
2 min read
Save

Circumcision prevents HIV among men who have sex with men

Circumcision prevents HIV among men who have sex with men

Voluntary medical male circumcision was effective in preventing HIV infection among men who have sex with men, or MSM, according to a randomized controlled trial recently published in Annals of Internal Medicine.

News
May 24, 2024
2 min read
Save

WHO reports ‘major’ global increase in STIs

WHO reports ‘major’ global increase in STIs

WHO reported a “major” increase in STIs in 2022, specifically highlighting an increase in syphilis and an insufficient decline in new HIV and viral hepatitis infections.

News
May 20, 2024
3 min read
Save

Q&A: AAP reverses stance on breastfeeding with HIV

Q&A: AAP reverses stance on breastfeeding with HIV

The AAP reversed its long-held stance against breastfeeding with HIV, now saying that parents with HIV who wish to breastfeed should be supported in their decision, so long as they are on treatment and virally suppressed.

News
May 09, 2024
2 min read
Save

Three more countries eliminate congenital HIV, syphilis

Three more countries eliminate congenital HIV, syphilis

Belize, Jamaica and St. Vincent and the Grenadines became the latest nations to eliminate mother-to-child transmission of HIV and syphilis, the Pan American Health Organization (PAHO) announced.

News
May 08, 2024
2 min read
Save

Point-of-care saliva testing raised HIV screening rate at adolescent clinic

Point-of-care saliva testing raised HIV screening rate at adolescent clinic

TORONTO — An adolescent medicine clinic more than quadrupled its HIV screening rate by offering point-of-care saliva testing, according to findings presented at the Pediatric Academic Societies Meeting.

CME
Video

HIV Curbside Consults: Addressing Questions on Weight Gain and Desire for Injectable Therapy

HIV Curbside Consults: Addressing Questions on Weight Gain and Desire for Injectable Therapy
0.50 CME
0.50 CPE
30 MINS
$0 FEE
CME
Video

HIV Curbside Consults: Treatment of Complex Patients with HIV

HIV Curbside Consults: Treatment of Complex Patients with HIV
0.50 CME
0.50 CPE
30 MINS
$0 FEE
CME
Video

HIV Curbside Consults: Treating Patients With Multiple Comorbidities or Intolerance

HIV Curbside Consults: Treating Patients With Multiple Comorbidities or Intolerance
0.50 CME
0.50 CPE
30 MINS
$0 FEE
View more